Align Technology (ALGN) Cash from Financing Activities (2009 - 2026)
Align Technology (ALGN) reported Cash from Financing Activities of -$48.1 million for Q1 2026, up 76.72% year-over-year from -$27.2 million in Q1 2025, and up 50.59% quarter-over-quarter from -$97.4 million in Q4 2025.
Align Technology (ALGN) Cash from Financing Activities (2009 - 2026) Analysis & Trends
Align Technology (ALGN) has 18 years of Cash from Financing Activities data on file, last reported at -$48.1 million in Q1 2026.
- Cash from Financing Activities for Q1 2026 came in at -$48.1 million, up 76.72% year-over-year; the trailing twelve-month figure through Mar 2026 was -$306.0 million (up 44.45% YoY), and the FY2025 annual result was -$464.6 million, down 30.6% from the prior year.
- Cash from Financing Activities climbed to -$48.1 million in Q1 2026 per ALGN's latest filing, from -$97.4 million in the prior quarter.
- Over five years, Cash from Financing Activities peaked at $11.8 million in Q3 2023 and troughed at -$350.3 million in Q4 2023.
- A 5-year average of -$115.8 million and a median of -$97.4 million in 2025 frame the typical range for Cash from Financing Activities.
- The sharpest annual moves came in 2022 and 2024: Cash from Financing Activities soared 116.77% in 2022, then slumped 16179.16% in 2024.
- A 5-year view of Cash from Financing Activities shows it stood at -$200.2 million in 2022, then slumped by 74.98% to -$350.3 million in 2023, then jumped by 42.04% to -$203.0 million in 2024, then surged by 52.02% to -$97.4 million in 2025, then jumped by 50.59% to -$48.1 million in 2026.
- Business Quant data shows ALGN's Cash from Financing Activities at -$48.1 million in Q1 2026, -$97.4 million in Q4 2025, and -$64.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | -1.35 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | -414.00 Mn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | -13.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | -255.24 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | -308.70 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | -50.00 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | -75.80 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | -48.13 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | -11.00 Mn |
| 10 | Aptargroup | 7.72 Bn | 7.52 Bn | 351.91 Mn | -230.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -48.13 Mn |
| Mar 31, 2026 | -48.13 Mn |
| Dec 31, 2025 | -97.41 Mn |
| Dec 31, 2025 | -97.41 Mn |
| Sep 30, 2025 | -64.12 Mn |
| Sep 30, 2025 | -64.12 Mn |
| Jun 30, 2025 | -96.30 Mn |
| Jun 30, 2025 | -96.30 Mn |
| Mar 31, 2025 | -206.76 Mn |
| Mar 31, 2025 | -206.76 Mn |
| Dec 31, 2024 | -203.02 Mn |
| Dec 31, 2024 | -203.02 Mn |
| Sep 30, 2024 | 10.57 Mn |
| Sep 30, 2024 | 10.57 Mn |
| Jun 30, 2024 | -151.56 Mn |
| Jun 30, 2024 | -151.56 Mn |
| Mar 31, 2024 | -11.72 Mn |
| Mar 31, 2024 | -11.72 Mn |
| Dec 31, 2023 | -350.28 Mn |
| Dec 31, 2023 | -350.28 Mn |